Supplementary Figure S10 from Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
Year: 2024
Type: supplementary-materials
Abstract: KLHL6 loss does not score as a negative regulator of surface CD79B or Pola-V sensitivity in CRISPR screens of ABC DLBCL cell lines and KLHL6 loss does not sensitize to MMAE
Authors: Sean R. Corcoran, James D. Phelan, Jaewoo Choi, Galina Shevchenko, Rachel E. Fenner, Xin Yu, Sebastian Scheich, Tony Hsiao, Vivian M. Morris, Evangelia K. Papachristou, Kamal Kishore, Clive S. D’Santos, Yanlong Ji, Stefania Pittaluga, George W. Wright, Henning Urlaub, Kuan-Ting Pan, Thomas Oellerich, Jagan Muppidi, Daniel J. Hodson, Louis M. Staudt
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4402219953